(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

INIBIDORES DE LPXC E SEUS USOS

ArquivadaInvention PatentPCT · US2022044710

Application data

Invention Patent INIBIDORES DE LPXC E SEUS USOS de BLACKSMITH MEDICINES, INC. — IPC A61K 31/5377
Invention Patent INIBIDORES DE LPXC E SEUS USOS de BLACKSMITH MEDICINES, INC. — IPC A61K 31/5377. Drawing published by the INPI in the Industrial Property Gazette.

Number

112024006239

Type

Invention Patent

Filing

09/26/2022

Publication

07/09/2024

PCT

US2022044710

Progress at the INPI

  1. Filing09/26/22
  2. Publication07/09/24
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 09/26/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 01/06/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BLACKSMITH MEDICINES, INC.

US

Inventors

M. T. (pessoa física)

US

Technical data

Priority claims

US

63/249,166 · 09/28/2021

Abstract

INIBIDORES DE LPXC E SEUS USOS.São fornecidos neste documento compostos inibidores de LpxC, bem como composições farmacêuticas compreendendo os referidos compostos e métodos de uso dos mesmos no tratamento de doenças que se beneficiariam do tratamento com um inibidor de LpxC, incluindo infecções bacterianas gram-negativas, tais como infecções do trato urinário e semelhantes.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

01/06/2026

RPI 2870

Arquivamento - Art. 33 da LPI

#11.1

10/07/2025

RPI 2857

Notificação de entrada na fase nacional - PCT

#1.3

07/09/2024

RPI 2792

Alteração de dados cadastrais

#1.1

04/09/2024

RPI 2779

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.